Pharmaceutical Distribution Process Requires for Transparency Among All Constituents

Published: 2004-12-21 06:59:00

Updated: 2004-12-21 06:59:00

A number of instances surrounding negative sales practices by the pharmaceutical manufactures, such as irregular price discounts, premiums and rebates, is putting all the related industry constituents to keenly focus on the possible outcomes decided by the government, as the year approaches to it...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK